ESMO Immuno-Oncology Congress 2024: Event announcement
Meeting Announcement
Updates every hour. Last Updated: 29-Apr-2025 13:08 ET (29-Apr-2025 17:08 GMT/UTC)
Against the backdrop of an alarming increase in the number of people under 50 being diagnosed with bowel cancer, researchers are urging people to bump up their fibre intake and improve their eating habits if they want to reduce their risk of deadly digestive cancers.
Two studies by Flinders University expand on existing evidence that a diet rich in fruits, vegetables, whole grains, fish, legumes and dairy may protect against the risk of gastrointestinal (GI) cancers - including bowel - and improve the outcomes of these diseases.
Kumamoto University researchers have identified a powerful antibody that can neutralize a wide range of SARS-CoV-2 variants, including the elusive Omicron subvariants.
A new chimeric antigen receptor T cell (CAR-T) therapy has delivered promising results in treating patients with an aggressive blood cancer, in results from a clinical trial led by researchers at UCL and UCLH.
Ewing sarcoma is a tumour of the bones and soft tissues that occurs in children and young people. A quarter of patients do not respond well to therapy.
The group led by Ana Losada, at Spain’s National Cancer Research Centre (CNIO), has discovered an alteration in the most aggressive cases that affects genes never previously related to this disease.
This finding expands the list of potential prognostic markers and therapeutic targets in the most aggressive cases of Ewing sarcoma.
The new research is published in ‘EMBO Reports’.
A new Reichman University study examines how conflicting interpretations regarding breast implants risk the erosion of the reputation of the US Food and Drug Administration (FDA). The FDA frequently finds itself embroiled in public debates about the severity of side effects associated with drugs or medical devices it has approved. These debates typically generate differing viewpoints among the medical community, patients, and the general public, with some arguing that very serious side effects warrant significant regulatory intervention and others maintaining that such intervention is unnecessary.